SPOTLIGHT -
Slideshow
Author(s):
Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.
Upcoming Research Related to DLX-001 for Major Depressive Disorder
Blue Light Blockers: A Behavior Therapy for Mania
Treatment-Resistant Depression: Which Patients Respond to Ketamine vs ECT?
Blue Light, Depression, and Bipolar Disorder
Study Links Divorce to Genetic Predispositions for Psychiatric Disorders
New Phase 1 Data on DLX-001 for Patients With Major Depressive Disorder